查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048266

心血管數位健康市場－全球產業規模、佔有率、趨勢、機會、預測：按組件、最終用戶、地區和競爭格局分類，2021-2031年

Digital Health For Cardiovascular Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Software, Hardware, Services), By End User (Patients, Providers, Payers, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心血管疾病治療數位健康市場預計將從 2025 年的 413.1 億美元大幅成長至 2031 年的 635.8 億美元，複合年成長率為 7.45%。

該領域整合了多種旨在促進心臟疾病遠距離診斷和管理的技術，包括行動醫療應用程式、穿戴式感測器和遠端醫療平台。推動該市場成長要素是對病患監測的迫切需求，以及對更具成本效益的醫療保健解決方案日益成長的需求，而這些解決方案對於應對心臟疾病日益普遍的現狀至關重要。例如，美國心臟協會在2024年報告中指出，48.6%的美國成年人（近一半）將患有某種形式的心血管疾病。如此巨大的疾病負擔是推動遠端系統管理工具普及應用的主要動力，這些工具旨在減少患者再入院率並改善臨床療效。

市場概覽
預測期 2027-2031
市場規模：2025年 413.1億美元
市場規模：2031年 635.8億美元
複合年成長率：2026-2031年 7.45%
成長最快的細分市場 服務
最大的市場 北美洲

儘管心血管疾病數位健康市場擁有強勁的成長潛力，但仍面臨許多挑戰，主要體現在資料隱私和監管合規方面。嚴格的病患資料安全法律體制嚴重阻礙了設備互通性以及在不同平台間安全交換敏感健康資訊。這些複雜的監管要求不僅延長了新技術商業化所需的時間，也限制了其與現有醫療體系的無縫整合，最終減緩了該領域的創新步伐。

市場促進因素

全球心血管疾病盛行率的不斷上升是推動數位醫療領域發展的根本動力，亟需對醫療服務和資金籌措模式進行變革。隨著心臟病日益普遍，醫療系統被迫採用遠端系統管理解決方案來控制成本並避免昂貴的住院。預計的巨額支出凸顯了這個財務需求。例如，美國心臟協會在2024年6月報告稱，美國每年用於心血管疾病的醫療支出將從2020年的3930億美元成長近四倍，到2050年達到1.49兆美元。這促使保險公司和醫療服務提供者積極採用數位平台，以促進預防性護理並減輕急性心臟疾病帶來的經濟負擔。

同時，人工智慧 (AI) 和機器學習 (ML) 在預測性診斷領域的融合，正透過提升穿戴式裝置的臨床價值，徹底改變市場格局。這些先進技術能夠對生物特徵數據進行持續分析，與傳統診斷方法相比，顯著提高了心律不整和其他心臟異常的早期檢出率。例如，杜克大學醫學中心於 2024 年 9 月發表的一項研究表明，與標準治療相比，長期連續心電圖監測可將心房顫動的診斷率提高 52%。診斷準確性的提升也得益於監管趨勢的不斷演變，這些趨勢正日益核准這些先進技術應用於更廣泛的臨床領域。根據《心血管商業》雜誌報道，到 2025 年，循環系統將成為第二大醫學專科，屆時將有約 160 種獲得 FDA核准的臨床人工智慧演算法。

市場挑戰

嚴格的資料隱私保護和監管合規性是全球心血管護理領域數位健康市場擴張的主要障礙。行動應用和穿戴式感測器製造商必須遵守複雜的法律體制，以確保其產品符合嚴格的患者資料保護標準。這種巨大的監管負擔將大量資金從產品創新轉移到合規體系，導致新型遠端監測技術進入市場的速度放緩。因此，中小企業往往難以進入該領域，導致競爭減少，並減緩了惠及心臟病患者的整體技術進步速度。

此外，保護可互通設備免受資料外洩的難度也阻礙了醫療機構的快速採用。對敏感健康資訊外洩風險的擔憂迫使各機構制定嚴格的資料共用協議，從而阻礙了有效遠端系統管理所需的順暢資訊交流。例如，醫療資訊與管理系統協會 (HIMSS) 的一份報告指出，到 2025 年，55% 的醫療機構計劃增加網路安全支出以降低這些漏洞。這種將資源重新分配到安全和合規的趨勢凸顯了隱私問題對醫療產業帶來的經濟壓力，最終限制了數位工具在傳統循環系統照護中的廣泛應用。

市場趨勢

無袖帶血壓測量技術的革新正在徹底改變高血壓管理，它消除了傳統充氣袖帶帶來的身體不適。這一新趨勢將光學感測器整合到易於使用的穿戴式設備中，實現持續、被動的數據收集，從而提供全面、長期的心血管健康觀點。根據 MobiHealthNews 於 2025 年 7 月報道，Aktiia 的 G0 血壓監測系統獲得了 FDA 510(k) 批准，成為美國首個核准非處方 (OTC) 使用的無袖帶血壓監測儀。這項重要的監管成就顯示市場正向被動監測解決方案轉變，這將提高使用者的依從性，並能夠在不干擾日常生活的情況下及早發現高血壓相關事件。

同時，向虛擬心臟復健模式的顯著轉變正在有效克服以往阻礙患者參與復健計畫的傳統障礙，例如地理限制和時間安排柔軟性。透過利用行動平台，醫療服務提供者現在可以將指導性運動計畫和必要的教育資源直接送到患者家中，從而顯著提高依從性和臨床療效。例如，本森亨利研究所 (Benson Henry Institute) 在 2025 年 9 月發布的聲明中重點介紹了麻省總醫院布萊根分院 (Massachusetts General Hospital Brigham) 與 Recora 之間的合作，該合作表明，參與 Recora 虛擬康復計劃的患者再入院率比接受傳統機構康復的患者降低了 38%。這一趨勢凸顯了醫療產業向混合型醫療服務模式的轉變，該模式優先考慮便利性，以改善急性期後心血管疾病的預後。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：心血管數位健康市場的全球展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（軟體、硬體、服務）
    • 按最終用戶（患者、醫療保健提供者、保險公司、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心血管數位健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心血管數位健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心血管數位健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心血管數位健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲心血管數位健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球心血管數位健康市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Apple Inc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • Medtronic plc
  • Fitbit, Inc.
  • AliveCor, Inc.
  • Withings SA
  • Dexcom, Inc.
  • Samsung Electronics Co., Ltd.
  • Huawei Technologies Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 28118

The global market for digital health in cardiovascular care is projected to expand significantly, from USD 41.31 Billion in 2025 to USD 63.58 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 7.45%. This sector integrates various technologies, including mobile health applications, wearable sensors, and telehealth platforms, all designed to facilitate the remote diagnosis and management of heart conditions. Key growth drivers for this market stem from the urgent need for continuous patient monitoring and the push for more cost-effective healthcare solutions, crucial for addressing the increasing prevalence of heart diseases. For instance, the American Heart Association reported in 2024 that nearly half, 48.6%, of adults in the United States suffer from some form of cardiovascular disease. This considerable disease burden is a major catalyst for the adoption of remote management tools, which aim to reduce hospital readmissions and enhance clinical outcomes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 41.31 Billion
Market Size 2031USD 63.58 Billion
CAGR 2026-20317.45%
Fastest Growing SegmentServices
Largest MarketNorth America

Despite this robust growth potential, the digital health for cardiovascular market encounters considerable hurdles, primarily concerning data privacy and adherence to regulatory standards. Stringent legal frameworks governing the security of patient data pose significant obstacles to device interoperability and the secure exchange of sensitive health information across diverse platforms. These intricate regulatory requirements not only prolong the time it takes for new technologies to reach commercialization but also restrict their seamless integration into established medical practices, thereby slowing innovation within the sector.

Market Driver

The escalating global prevalence of cardiovascular diseases serves as a fundamental driver for the digital health sector, demanding urgent transformations in healthcare delivery and financing models. With heart conditions becoming increasingly common, healthcare systems are compelled to adopt remote management solutions to control costs and avoid costly hospitalizations. This financial necessity is highlighted by significant projected expenditures; for example, the American Heart Association reported in June 2024 that annual healthcare costs for cardiovascular conditions in the United States are expected to nearly quadruple from $393 billion in 2020 to $1,490 billion by 2050. This drives payers and providers to actively integrate digital platforms that facilitate preventive care and alleviate the economic burden associated with acute cardiac events.

Concurrently, the integration of Artificial Intelligence (AI) and Machine Learning (ML) for predictive diagnostics is revolutionizing the market by boosting the clinical value of wearable devices. These advanced technologies enable continuous analysis of biometric data, which substantially improves the early detection of arrhythmias and other cardiac anomalies compared to conventional diagnostic approaches. A study from Duke University Medical Center in September 2024, for instance, found that long-term continuous heart monitors increased the diagnosis of atrial fibrillation by 52% compared to standard care. This enhanced diagnostic accuracy is further bolstered by an evolving regulatory landscape that is increasingly validating these sophisticated technologies for broader clinical application, with cardiology ranking second among all specialties in 2025, featuring approximately 160 FDA-cleared clinical AI algorithms according to Cardiovascular Business.

Market Challenge

The rigorous enforcement of data privacy and regulatory compliance presents a significant obstacle to the expansion of the global digital health market for cardiovascular care. Producers of mobile applications and wearable sensors are obligated to navigate intricate legal structures to ensure their products adhere to stringent patient data protection standards. This extensive regulatory load diverts substantial capital towards compliance infrastructure rather than product innovation, consequently postponing the market entry of new remote monitoring technologies. As a result, smaller companies often find it difficult to penetrate this sector, which diminishes competition and decelerates the overall rate of technological progress benefiting cardiac patients.

Furthermore, the difficulty in safeguarding interoperable devices from data breaches inhibits swift adoption by healthcare organizations. The inherent risk of compromising sensitive health information compels these institutions to establish restrictive data-sharing protocols, which in turn impede the fluid information exchange essential for effective remote management. For example, the Healthcare Information and Management Systems Society reported that in 2025, 55 percent of healthcare organizations intended to boost their cybersecurity spending to mitigate these vulnerabilities. This reallocation of financial resources towards security and compliance underscores the economic pressure that privacy concerns exert on the industry, ultimately restricting the widespread integration of digital tools into conventional cardiovascular care.

Market Trends

The evolution of cuffless blood pressure monitoring technologies is revolutionizing hypertension management by removing the physical discomfort typically linked with conventional inflatable cuffs. This emerging trend involves embedding optical sensors into user-friendly wearable devices, allowing for continuous and passive data collection to provide a comprehensive, long-term perspective on cardiovascular health. As reported by MobiHealthNews in July 2025, Aktiia achieved FDA 510(k) clearance for its G0 Blood Pressure Monitoring System, making it the first cuffless monitor approved for over-the-counter use in the United States. This significant regulatory achievement indicates a market movement towards passive monitoring solutions, which improve user adherence and facilitate the early identification of hypertensive events without interfering with daily life.

Concurrently, a notable shift towards virtual cardiac rehabilitation models is effectively overcoming traditional barriers like geographical restrictions and inflexible scheduling that have historically hindered patient participation in recovery programs. By utilizing mobile platforms, healthcare providers can now deliver supervised exercise regimens and essential educational resources directly to patients' homes, substantially increasing adherence and clinical effectiveness. For instance, a collaboration between Mass General Brigham and Recora, announced by the Benson-Henry Institute in September 2025, highlighted a study where patients participating in Recora's virtual program experienced a 38 percent reduction in hospital readmissions compared to those in traditional center-based rehabilitation. This trend emphasizes the industry's transition towards hybrid care delivery frameworks that prioritize convenience to enhance post-acute cardiovascular outcomes.

Key Market Players

  • Apple Inc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • Medtronic plc
  • Fitbit, Inc.
  • AliveCor, Inc.
  • Withings SA
  • Dexcom, Inc.
  • Samsung Electronics Co., Ltd.
  • Huawei Technologies Co., Ltd.

Report Scope

In this report, the Global Digital Health For Cardiovascular Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Health For Cardiovascular Market, By Component

  • Software
  • Hardware
  • Services

Digital Health For Cardiovascular Market, By End User

  • Patients
  • Providers
  • Payers
  • Others

Digital Health For Cardiovascular Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Health For Cardiovascular Market.

Available Customizations:

Global Digital Health For Cardiovascular Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Health For Cardiovascular Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Software, Hardware, Services)
    • 5.2.2. By End User (Patients, Providers, Payers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Digital Health For Cardiovascular Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Health For Cardiovascular Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Digital Health For Cardiovascular Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Digital Health For Cardiovascular Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By End User

7. Europe Digital Health For Cardiovascular Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Health For Cardiovascular Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By End User
    • 7.3.2. France Digital Health For Cardiovascular Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Digital Health For Cardiovascular Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Digital Health For Cardiovascular Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Digital Health For Cardiovascular Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By End User

8. Asia Pacific Digital Health For Cardiovascular Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Health For Cardiovascular Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By End User
    • 8.3.2. India Digital Health For Cardiovascular Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Digital Health For Cardiovascular Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Digital Health For Cardiovascular Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Digital Health For Cardiovascular Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By End User

9. Middle East & Africa Digital Health For Cardiovascular Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Health For Cardiovascular Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Digital Health For Cardiovascular Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Digital Health For Cardiovascular Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By End User

10. South America Digital Health For Cardiovascular Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Health For Cardiovascular Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Digital Health For Cardiovascular Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Digital Health For Cardiovascular Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Health For Cardiovascular Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Apple Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Philips Healthcare
  • 15.3. Boston Scientific Corporation
  • 15.4. Medtronic plc
  • 15.5. Fitbit, Inc.
  • 15.6. AliveCor, Inc.
  • 15.7. Withings SA
  • 15.8. Dexcom, Inc.
  • 15.9. Samsung Electronics Co., Ltd.
  • 15.10. Huawei Technologies Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer